HomeSRT3 • ETR
Sartorius AG Preference Shares
€250.30
Jan 27, 8:30:00 PM GMT+1 · EUR · ETR · Disclaimer
StockDE listed security
Previous close
€249.00
Day range
€245.20 - €251.80
Year range
€199.50 - €383.70
Market cap
16.74B EUR
Avg Volume
85.08K
P/E ratio
205.79
Dividend yield
0.29%
CDP Climate Change Score
C
Market news
Financials
Income Statement
Revenue
Net income
(EUR)Sep 2024Y/Y change
Revenue
793.60M-2.11%
Operating expense
276.90M5.45%
Net income
14.20M-4.70%
Net profit margin
1.79-2.72%
Earnings per share
0.87-17.92%
EBITDA
169.60M-6.56%
Effective tax rate
26.95%—
Total assets
Total liabilities
(EUR)Sep 2024Y/Y change
Cash and short-term investments
579.20M97.07%
Total assets
9.79B-1.67%
Total liabilities
6.02B-16.62%
Total equity
3.78B—
Shares outstanding
——
Price to book
——
Return on assets
1.73%—
Return on capital
2.04%—
Net change in cash
(EUR)Sep 2024Y/Y change
Net income
14.20M-4.70%
Cash from operations
266.10M47.92%
Cash from investing
-93.50M96.05%
Cash from financing
-186.20M-108.01%
Net change in cash
-12.00M-109.11%
Free cash flow
111.86M1,064.33%
About
Sartorius AG is an international pharmaceutical and laboratory equipment supplier, covering the segments of Bioprocess Solutions and Lab Products & Services. In September 2021, Sartorius has been admitted to the DAX, Germany's largest stock market index. As a leading partner to the biopharmaceutical research and industry, Sartorius supports its customers in the development and production of biotech drugs and vaccines - from the initial idea in the laboratory to commercial production. Sartorius conducts its operating business in the two divisions Bioprocess Solutions and Lab Products&Services. The divisions bundle their respective businesses according to the same application areas and customer groups. The divisions share some of the infrastructure and central services. Wikipedia
Founded
1870
Employees
13,762
Search
Clear search
Close search
Google apps
Main menu